Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | AFAMELANOTIDE (Scenesse (TN)) | [1] Afamelanotide Afamelanotide (Scenesse) | [1] Afamelanotide
Afamelanotide
(Scenesse (TN)) 💬
| [1] MC1R MC1R 💬
| [2] Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [2] 159 159, 254 💬
|
| 2 | Afamelanotide (16 mg implant) (Scenesse (TN)) | [1] Afamelanotide Afamelanotide (Scenesse) | [1] Afamelanotide
Afamelanotide
(Scenesse (TN)) 💬
| [1] MC1R MC1R 💬
| [2] Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 159 159 💬
|
| 3 | Afamelanotide Implant (Scenesse (TN)) | [1] Afamelanotide Afamelanotide (Scenesse) | [1] Afamelanotide
Afamelanotide
(Scenesse (TN)) 💬
| [1] MC1R MC1R 💬
| [2] Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [1] 254 254 💬
|
| 4 | SCENESSE | [1] Afamelanotide Afamelanotide (Scenesse) | [1] Afamelanotide
Afamelanotide
(Scenesse (TN)) 💬
| [1] MC1R MC1R 💬
| [2] Melanogenesis Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [3] 159 159, 161, 254 💬
|